Definitive Contract HHSO100201300009C

Award Date 5/24/13
Potential Completion Date 10/31/18
Potential Value $66M
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Chapel Hill, NC, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
<p>This is a $323,554,976.00 Firm Fixed Price definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to Paratek Pharmaceuticals, Inc. for the development of an antibiotic to treat a biothreat indication. The contract has an ultimate completion date of December 17, 2029 and was awarded on December 18, 2019. This contract is not associated with a set-aside program.</p>
This federal contract award, valued at $8,140.32, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Ciprofloxacin HCL 250 mg tablets, a critical antibiotic medication, to support military healthcare programs. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to...
This is a $27,032,719.27 cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Spero Therapeutics, Inc. to advance the clinical and non-clinical development of an antibiotic candidate. The contract is not set aside. The contract originated from a NIAID Broad Agency Announcement (BAA) soliciting proposals for the advanced development of vaccine candidates, therapeutic products, and diagnostics to address biodefense, antimicrobial...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,563,681,935 units of Ciprofloxacin HCL 250 mg tablets. The contract has a ceiling value of $4,407.09 and a completion date of February 16, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This is a $237,994,127.86 definitive cost-reimbursement contract awarded by the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response to Hoffmann-La Roche Inc. for the &quot;COMBATING MULTI-DRUG RESISTANCE AND ADDRESSING EMERGING BACTERIAL THREATS: DISCOVERY, CLINICAL DEVEL&quot; program. The contract has a period of performance through September 30, 2027 and does not have a set-aside designation. The contract supports the agency's efforts to...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Ciprofloxacin HCl 500 mg tablets. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which serves as a primary vehicle for DLA to procure a comprehensive range of medical commodities to support military treatment programs and...
This federal contract award, valued at $1,645.02, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,563,293,309 units of Erythromycin 250 mg tablets, a pharmaceutical product used in the treatment of various bacterial infections. The contract is a Firm Fixed Price Delivery Order, with a completion date of January 11, 2024. This award is part of a larger Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,226.01 firm fixed-price delivery order is for 4,560,911,252 units of Ciprofloxacin HCL 500 MG Tablets, with a completion date of May 12, 2023. The contract is not designated with a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $14,473.21 firm-fixed-price delivery order is for the supply of Cefixime 400 mg capsules, a common antibiotic medication. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00. This single-award IDC serves as the primary...
This federal contract award is for the delivery of 4,558,280,789 units of Ciprofloxacin HCL 250 mg tablets to the Defense Logistics Agency (DLA). The $1,032.68 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 30, 2022, with an ultimate completion date of August 31, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle...

This is a $65,746,932.93 cost-plus-fixed-fee definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian federal agency, to Cempra Pharmaceuticals, Inc., a subsidiary of Melinta Therapeutics, LLC. The contract is for the development of SOLITHROMYCIN (CEM-101) for civilian use and as a broad bioterror threat medical countermeasure. The contract has an ultimate completion date of October 31, 2018 and was awarded on May 24, 2013. The contract is not set aside.

Generated 8/31/24, 11:45 AM